BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27865435)

  • 1. The pulse-mass index as a predictor of cardiovascular events in women with systemic lupus erythematosus.
    García-Villegas EA; Márquez-González H; Flores-Suárez LF; Villa-Romero AR
    Med Clin (Barc); 2017 Jan; 148(2):57-62. PubMed ID: 27865435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of metabolic syndrome for the development of cardiovascular disease in a cohort of premenopausal women with systemic lupus erythematosus.
    García-Villegas EA; Lerman-Garber I; Flores-Suárez LF; Aguilar-Salinas C; Márquez González H; Villa-Romero AR
    Med Clin (Barc); 2015 Apr; 144(7):289-96. PubMed ID: 25458513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal-placental syndrome and future risk of accelerated cardiovascular events in Parous Swedish women with systemic lupus erythematosus - a population-based retrospective cohort study with time-to-event analysis.
    Soh MC; Dib F; Nelson-Piercy C; Westgren M; McCowan L; Pasupathy D
    Rheumatology (Oxford); 2016 Jul; 55(7):1235-42. PubMed ID: 27016663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
    Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
    J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
    Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased visceral adipose tissue and altered adiposity distribution in premenopausal lupus patients: correlation with cardiovascular risk factors.
    Seguro LPC; Paupitz JA; Caparbo VF; Bonfa E; Pereira RMR
    Lupus; 2018 May; 27(6):1001-1006. PubMed ID: 29451068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus.
    Jönsen A; Clarke AE; Joseph L; Belisle P; Bernatsky S; Nived O; Bengtsson AA; Sturfelt G; Pineau CA
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1233-7. PubMed ID: 21618451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.
    Demir S; Artim-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Omma A; Erer B; Kamalı S; Gül A; Aral O; Öcal L; İnanç M
    Lupus; 2016 Feb; 25(2):177-84. PubMed ID: 26354963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major adverse cardiovascular events and mortality in systemic lupus erythematosus patients after successful delivery: a population-based study.
    Wu LS; Tang CH; Lin YS; Lin CP; Hung ST; Hwa HL; Luo SF; Chu PH
    Am J Med Sci; 2014 Jan; 347(1):42-9. PubMed ID: 23255242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the metabolic syndrome severity index as a predictive factor of a major cardiovascular event in premenopausal women with systemic lupus erythematosus.
    García-Villegas EA; Vargas-de-León C; Villa-Romero AR; Ibarra Valdovinos I; Márquez-González H
    Med Clin (Barc); 2024 May; ():. PubMed ID: 38697892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.
    Barbhaiya M; Feldman CH; Guan H; Gómez-Puerta JA; Fischer MA; Solomon DH; Everett B; Costenbader KH
    Arthritis Rheumatol; 2017 Sep; 69(9):1823-1831. PubMed ID: 28598016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease.
    Al Rayes H; Harvey PJ; Gladman DD; Su J; Sabapathy A; Urowitz MB; Touma Z
    Arthritis Res Ther; 2017 Feb; 19(1):31. PubMed ID: 28183339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.
    Hendler JV; de Souza L; de Freitas Zernow DC; Guimarães J; Bertotto T; Saldanha CF; Brenol JCT; Monticielo OA
    Clin Rheumatol; 2017 Sep; 36(9):2005-2010. PubMed ID: 28653264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
    Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
    Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus Damage and Waist Circumference as the Independent Risk Factors for Cardiovascular Disease in SLE Patients from Phramongkutklao Hospital.
    Siricheepchaiyan W; Narongroeknawin P; Pakchotanon R; Asavatanabodee P; Chaiamnuay S
    J Med Assoc Thai; 2016 Mar; 99(3):290-300. PubMed ID: 27276740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years.
    Ajeganova S; Hafström I; Frostegård J
    Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33547230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
    Mauro D; Nerviani A
    Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
    Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
    Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.